Stock listing
Xetra:42Z Revolution Medicines, Inc. Aktie
German listing (Xetra) of Revolution Medicines, Inc. · home listing NASDAQ:RVMD
Follow Revolution Medicines, Inc. into a list and get an email when it puts out news.
Home listing price · NASDAQ:RVMD
$159.82 USD -2.87 (-1.8%)
Close on Nov 18, 2026 · This listing has no price on 6ix; the price shown is the home listing's, NASDAQ:RVMD
- Day range
- $158.41 – $163.04 USDNov 18, 2026
- Volume
- 2.34M sharesNov 18, 2026
- Market cap
- $34.57B USDAt the close on Nov 18, 2026 · price × 216.3M shares outstanding
- 52-week range
- $69.50 – $224.31 USDLowest and highest trades, Nov 19, 2025 – Nov 18, 2026
- Traded on an average day
- $424.8M USDMedian day 1.86M shares · last 3 months, Aug 18, 2026 – Nov 18, 2026

Prices by listing
| Listing | Last | Change | Volume | Open | High | Low | Previous close | Price from |
|---|---|---|---|---|---|---|---|---|
| NASDAQ:RVMD · Home | $159.82 USD | -2.87 (-1.8%) | 2,339,689 | $161.65 | $163.04 | $158.41 | $162.69 | Close on Nov 18, 2026 |
| Frankfurt:42Z | €144.00 EUR | -2.45 (-1.7%) | 307 | €148.15 | €149.75 | €144.00 | €146.45 | Close on Nov 18, 2026 |
Daily closes
Last 3 months, Aug 18, 2026 – Nov 18, 2026 · NASDAQ:RVMD · USD, adjusted for splits
| Day | Close | Change | % | Open | High | Low | Volume |
|---|---|---|---|---|---|---|---|
| $159.82 | -2.87 | -1.8% | $161.65 | $163.04 | $158.41 | 2,339,689 | |
| $162.69 | -4.18 | -2.5% | $166.87 | $167.99 | $161.69 | 2,686,001 | |
| $166.87 | -5.42 | -3.1% | $172.00 | $173.59 | $165.95 | 2,504,991 | |
| $172.29 | -4.06 | -2.3% | $176.02 | $176.06 | $168.62 | 2,654,011 | |
| $176.35 | -4.35 | -2.4% | $181.33 | $181.33 | $176.19 | 3,221,898 | |
| $180.70 | -12.36 | -6.4% | $192.82 | $193.35 | $180.45 | 3,256,932 | |
| $193.06 | -7.09 | -3.5% | $197.31 | $198.95 | $189.76 | 2,069,291 | |
| $200.15 | +7.87 | +4.1% | $194.97 | $201.11 | $191.60 | 2,560,214 | |
| $192.28 | +14.63 | +8.2% | $184.87 | $195.02 | $181.27 | 4,495,800 | |
| $177.65 | -22.05 | -11.0% | $209.05 | $209.29 | $177.12 | 7,804,569 | |
| $199.70 | +5.47 | +2.8% | $198.50 | $201.79 | $192.34 | 2,494,920 | |
| $194.23 | +6.06 | +3.2% | $188.63 | $197.00 | $188.63 | 1,387,245 | |
| $188.17 | -3.14 | -1.6% | $190.71 | $192.98 | $187.12 | 1,289,153 | |
| $191.31 | +1.04 | +0.5% | $188.38 | $192.60 | $187.28 | 1,099,311 | |
| $190.27 | +1.55 | +0.8% | $187.38 | $191.90 | $187.37 | 1,322,600 | |
| $188.72 | +2.50 | +1.3% | $185.04 | $188.85 | $183.86 | 889,416 | |
| $186.22 | +2.32 | +1.3% | $182.02 | $187.66 | $181.20 | 1,171,918 | |
| $183.90 | -3.09 | -1.7% | $186.99 | $188.30 | $181.00 | 1,659,864 | |
| $186.99 | -0.70 | -0.4% | $187.59 | $189.52 | $183.61 | 1,721,800 | |
| $187.69 | -6.59 | -3.4% | $192.06 | $194.59 | $185.34 | 1,487,100 | |
| $194.28 | -2.27 | -1.2% | $198.71 | $203.49 | $193.97 | 1,875,900 | |
| $196.55 | +14.40 | +7.9% | $181.50 | $197.14 | $180.00 | 2,737,000 | |
| $182.15 | +4.19 | +2.4% | $179.98 | $183.87 | $177.00 | 1,978,600 | |
| $177.96 | -11.30 | -6.0% | $188.86 | $189.68 | $175.91 | 2,973,600 | |
| $189.26 | -4.26 | -2.2% | $193.31 | $195.94 | $189.14 | 1,568,400 | |
| $193.52 | +5.08 | +2.7% | $186.84 | $197.00 | $185.88 | 2,462,900 | |
| $188.44 | -5.51 | -2.8% | $191.57 | $193.61 | $187.14 | 2,941,500 | |
| $193.95 | +4.19 | +2.2% | $187.79 | $194.26 | $184.76 | 1,667,400 | |
| $189.76 | +1.64 | +0.9% | $186.01 | $193.50 | $184.37 | 2,210,300 | |
| $188.12 | -12.75 | -6.3% | $198.51 | $199.64 | $180.49 | 4,856,800 | |
| $200.87 | +1.00 | +0.5% | $198.18 | $203.50 | $196.25 | 1,184,900 | |
| $199.87 | -7.81 | -3.8% | $208.57 | $208.57 | $195.00 | 1,631,600 | |
| $207.68 | +1.04 | +0.5% | $207.68 | $210.27 | $201.83 | 1,424,300 | |
| $206.64 | +0.75 | +0.4% | $205.89 | $208.82 | $204.07 | 1,570,300 | |
| $205.89 | +0.63 | +0.3% | $204.00 | $210.88 | $203.26 | 2,103,900 | |
| $205.26 | +0.78 | +0.4% | $205.48 | $209.79 | $203.00 | 1,844,700 | |
| $204.48 | +2.74 | +1.4% | $201.41 | $204.96 | $200.00 | 1,721,900 | |
| $201.74 | -3.23 | -1.6% | $203.97 | $204.98 | $200.98 | 1,814,500 | |
| $204.97 | +5.11 | +2.6% | $200.54 | $211.51 | $197.97 | 2,520,300 | |
| $199.86 | +9.12 | +4.8% | $190.15 | $201.28 | $189.84 | 4,061,800 | |
| $190.74 | -2.12 | -1.1% | $193.30 | $196.71 | $189.05 | 2,124,800 | |
| $192.86 | +0.10 | +0.1% | $191.56 | $195.28 | $191.22 | 1,881,800 | |
| $192.76 | +1.81 | +0.9% | $192.61 | $194.93 | $190.57 | 1,888,600 | |
| $190.95 | -5.99 | -3.0% | $197.00 | $197.10 | $188.18 | 5,938,100 | |
| $196.94 | +1.02 | +0.5% | $198.53 | $202.02 | $194.80 | 1,820,800 | |
| $195.92 | -8.94 | -4.4% | $204.84 | $205.15 | $193.58 | 3,036,700 | |
| $204.86 | -0.25 | -0.1% | $206.98 | $207.00 | $200.24 | 1,268,500 | |
| $205.11 | +1.34 | +0.7% | $203.50 | $206.55 | $200.17 | 1,273,600 | |
| $203.77 | +0.42 | +0.2% | $204.98 | $206.36 | $197.81 | 1,378,500 | |
| $203.35 | -4.33 | -2.1% | $205.85 | $207.84 | $202.59 | 810,400 | |
| $207.68 | +0.36 | +0.2% | $206.01 | $213.00 | $204.46 | 1,227,000 | |
| $207.32 | -2.70 | -1.3% | $208.07 | $213.00 | $206.30 | 2,390,100 | |
| $210.02 | -0.85 | -0.4% | $209.01 | $211.75 | $207.48 | 884,500 | |
| $210.87 | +1.64 | +0.8% | $207.04 | $212.06 | $207.04 | 1,119,100 | |
| $209.23 | -0.64 | -0.3% | $211.36 | $211.91 | $205.22 | 1,329,600 | |
| $209.87 | +4.30 | +2.1% | $204.64 | $210.26 | $202.54 | 1,830,200 | |
| $205.57 | -2.31 | -1.1% | $205.14 | $207.02 | $200.53 | 2,268,800 | |
| $207.88 | -13.27 | -6.0% | $221.50 | $221.50 | $205.82 | 2,005,000 | |
| $221.15 | +5.71 | +2.7% | $219.48 | $224.31 | $216.13 | 3,359,200 | |
| $215.44 | +4.06 | +1.9% | $209.32 | $218.30 | $198.91 | 3,524,100 | |
| $211.38 | -0.20 | -0.1% | $214.27 | $216.24 | $209.63 | 1,377,300 | |
| $211.58 | +2.12 | +1.0% | $209.46 | $211.95 | $205.39 | 1,598,000 | |
| $209.46 | -2.275 | -1.1% | $212.06 | $212.74 | $206.75 | 2,124,000 | |
| $211.74 | -2.925 | -1.4% | $212.26 | $213.74 | $208.02 | 1,563,400 | |
| $214.66 | -1.34 | -0.6% | $218.84 | $220.34 | $212.25 | 1,307,800 | |
| $216.00 | +4.00 | +1.9% | $209.15 | $216.72 | $209.09 | 1,651,900 |
- Ticker
- Xetra:42Z
- Asset type
- Stock
- Exchange
- Xetra
- Currency
- EUR
What changed lately
Latest news release · Nov 16, 2026
European Commission Approves Revolution Medicines’ RASONQUE® (daraxonrasib), the First Broad RAS-Targeted Medicine in Metastatic Pancreatic Cancer
Latest earnings call · Nov 4, 2026
Revolution Medicines (NASDAQ:RVMD) Q3 2026 Earnings Call
Replay and transcript
Latest deck · Aug 26, 2026
Investor Presentation (August 2026)
Investor deck · 33 slides
Calls
Replays
Revolution Medicines (NASDAQ:RVMD) Q3 2026 Earnings Call
Wed, Nov 04, 2026 · 4:30 PM ET
Watch TranscriptRevolution Medicines (NASDAQ:RVMD) Q2 2026 Earnings Call
Wed, Aug 05, 2026 · 4:30 PM ET
Watch TranscriptRevolution Medicines (NASDAQ:RVMD) Q1 2026 Earnings Call
Wed, May 06, 2026 · 4:30 PM ET
Watch Transcript
Latest news
European Commission Approves Revolution Medicines’ RASONQUE® (daraxonrasib), the First Broad RAS-Targeted Medicine in Metastatic Pancreatic Cancer
Nov 16, 2026
Closed $166.87 (-3.1%) on Nov 16, 2026
Revolution Medicines Reports Third Quarter 2026 Financial Results and Update on Corporate Progress
Nov 4, 2026
Closed $177.65 (-11.0%) on Nov 5, 2026
Medicilon Presents Revolution Medicines with the "Excellence in Client Partnership Award"
Oct 30, 2026
Closed $191.31 (+0.5%) on Oct 30, 2026
Revolution Medicines to Participate in November 2026 Investor Conferences
Oct 27, 2026
Closed $188.72 (+1.3%) on Oct 28, 2026
Revolution Medicines Presents Overall Survival Data for RASONQUE™ (daraxonrasib) Across Subgroups in Previously Treated Metastatic Pancreatic Cancer at ESMO 2026
Oct 23, 2026
Closed $186.99 (-0.4%) on Oct 23, 2026
Revolution Medicines to Report Financial Results for Third Quarter 2026 After Market Close on November 4, 2026
Oct 21, 2026
Closed $187.69 (-3.4%) on Oct 22, 2026
Revolution Medicines Begins Treating Patients in Phase 3 RASolve 308 Trial Evaluating Zoldonrasib in Combination with Pembrolizumab and Chemotherapy as First-Line Treatment for Patients with Metastatic RAS G12D Non-Squamous Non-Small Cell Lung Cancer
Oct 20, 2026
Closed $196.55 (+7.9%) on Oct 20, 2026
Revolution Medicines’ RASONQUE™ (daraxonrasib) Receives Positive CHMP Opinion Recommending Marketing Authorization in European Union for Metastatic Pancreatic Cancer
Oct 15, 2026
Closed $189.26 (-2.2%) on Oct 15, 2026
Financings
Public offering of common stock
Apr 17, 2026
Closed: US$1.5B raised · US$142 a share · J.P. Morgan +3
Dealers: J.P. Morgan (co-lead), TD Cowen (co-lead), Guggenheim Securities (co-lead), LifeSci Capital
Use of proceeds: General corporate purposes, including R&D, potential commercialization of product candidates, G&A expenses and capital expenditures
Announced Apr 13, 2026 · Made bigger Apr 15, 2026 · Closed Apr 17, 2026
0.50% convertible senior notes due 2033
Apr 17, 2026
Closed: US$500M raised · J.P. Morgan +3
Dealers: J.P. Morgan (co-lead), TD Cowen (co-lead), Guggenheim Securities (co-lead), LifeSci Capital
Use of proceeds: General corporate purposes, including R&D, potential commercialization of product candidates, G&A expenses and capital expenditures
Announced Apr 13, 2026 · Made bigger Apr 15, 2026 · Closed Apr 17, 2026
Synthetic royalty on daraxonrasib sales
Jun 24, 2025
Tranche closed: US$250M raised · TD Securities
Dealers: TD Securities
Buyers: Royalty Pharma (up to $1.25 billion in exchange for tiered royalties on daraxonrasib net sales)
Use of proceeds: Support independent global development and commercialization of its RAS(ON) inhibitor portfolio
Public offering of common stock and pre-funded warrants
Dec 5, 2024
Closed: US$862.5M raised · US$46 a share · J.P. Morgan +4
Dealers: J.P. Morgan (co-lead), TD Cowen (co-lead), Goldman Sachs & Co. LLC (co-lead), Guggenheim Securities (co-lead), UBS Investment Bank
Announced Dec 2, 2024 · Made bigger Dec 3, 2024 · Closed Dec 5, 2024
Decks
Investor Presentation (August 2026)
Investor deck · 33 slides · Aug 26, 2026
Investor Presentation (August 2026)
Investor deck · 99 slides · August 2026
Technical Presentation (July 2026)
Technical · 15 slides · July 2026
AACR 2026
Conference · 15 slides · April 2026
Revolution Medicines, Inc. on 6ix
- News releases
- 46 in the last 12 months · 173 in all · newest Nov 16, 2026 · oldest 2020
- Calls
- 22 calls with a replay · 22 with a transcript · latest Nov 4, 2026
- Decks
- 16 decks · latest Aug 26, 2026
Where Revolution Medicines, Inc. is listed
| Listing | Exchange | Country | Currency |
|---|---|---|---|
| NASDAQ:RVMD · Home listing | NASDAQ | United States | USD |
| gettex:42Z | gettex | Germany | EUR |
| LS Exchange:A2PYWG | LS Exchange | Germany | EUR |
| Milan:1RVMD | Milan | Italy | EUR |
| Tradegate:42Z | Tradegate | Germany | EUR |
| BX Swiss:RVMD | BX Swiss | Switzerland | CHF |
| BOATS:RVMD | BOATS | United States | USD |
| Lang & Schwarz:A2PYWG | Lang & Schwarz | Germany | EUR |
| BMV:RVMD | BMV | Mexico | MXN |
| Dusseldorf:42Z | Dusseldorf | Germany | EUR |
| Frankfurt:42Z | Frankfurt | Germany | EUR |
| Hamburg:42Z | Hamburg | Germany | EUR |
| Munich:42Z | Munich | Germany | EUR |
| Stuttgart:42Z | Stuttgart | Germany | EUR |
| BIVA:RVMD | BIVA | Mexico | MXN |
| Hanover:42Z | Hanover | Germany | EUR |
| Xetra:42Z · This page | Xetra | Germany | EUR |
Log in to ask 6ix AI your own questions about Revolution Medicines, Inc.